Keywords
Exclude

Select All | None | words selected.
Top 50 Keywords:
disease
immunoglobulin
monoclonal
nomenclature
antibody
biological
biosimilar
biotech
biotechnology
drug
immunology
infusion
injection
inn
mab
peptide
protein
receptor
interleukin
leukemia
immune
inhibitor
asthma
cd194
ctcl
chemokine
chronic
ccr4
atcll
sezary
afucosylated
lymphoma
mogamulizumab
mycosis
system
fungoides
ozogamicin
factor
acute
antibody-drug
calicheamicin
eosinophilic
conjugate
cancer
infection
inflammation
platelet
toxicity
breakthrough
orphan
Other Keywords:
kinase
growth
interleukin-5
derived
alpha
oncology
myeloid
gemtuzumab
fatal
cd33
olaratumab
cytotoxic
pdgfra
vhh
bivalent
caplacizumab
purpura
thrombocytopenic
thrombosis
cd125
thrombotic
von
liver
benralizumab
willebrand
tyrosine
tumor
sarcoma
cd22
aggregation
inotuzumab
single-domain
adaptive
lymphoblastic
kexin
tcdb
toxin
alirocumab
atherosclerosis
blocker
cardiovascular
cholesterol
cholesterolemia
convertase
enzyme
ldl
difficile

lipoprotein
pcsk9
proprotein
subtilisin
angioedema
hae
hereditary
kallikrein
kininogen
lanadelumab
recurrence
clostridium
auto-inflammatory
syndromes
beta
canakinumab
skin
caps
caspase
cryopyrin-associated
fever
il-1b
periodic
rare
eosinophil
bezlotoxumab
il-5
mepolizumab
severe
autoimmune
cytokine
il-23
il-23p19
inflammatory
interleukin-23
psoriasis
tildrakizumab
squamous
phex
programmed
science
medical
medicine
microbe
microbiology
name
neutrophile

on white
organism
research
set
macrophage
sick
structure
vector
virus
allergen
allergic
allergy
e
fc
mast cell
isometric
ige
education
anatomy
b cell
basophile
biology
bundle
collection
defense
dendric cell
disorder
educational
isolated
endotelial cell
eosinophile
health
health care
human
illness
illustration
immunity
innate
hypersensitivity
omalizumab
pd-1
headache
osteomalacia
anatomical
rickets
x-linked
calca

calcb
calcitonin-related
cluster
fremanezumab
ligand
hypophosphatemia
migraine
blockade
cd279
cell
cemiplimab
checkpoint
death
lung
myeloma
krn23
burosumab
sensitivity
organ
spontaneous
urticaria
basiliximab
cd25
chimeric
il-2
immunosuppressant
kidney
lichen
planus
post-attachment
rejection
transplant
transplantation
ccr5
cd4
cxcr4
entry
hiv
ibalizumab
plasma
  • Support
  • Updates
  • Donate
  • Privacy Statement